A. A. Roshchina
Research Subjects
A. A. Roshchina has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- E. V. Yakovleva
Ministry of Health and Social Development of the Russian Federation State Educational Institution of Higher Professional Education Saratov State Medical University named after V.I. Razumovsky
1 shared publication I. V. Basov
State Health Institution «Regional Clinical Hospital» of Saratov
1 shared publication- M. A. Tyapkina
Ministry of Health and Social Development of the Russian Federation State Educational Institution of Higher Professional Education Saratov State Medical University named after V.I. Razumovsky
1 shared publication M. I. Yupatova
Federal State Budgetary Educational Institution of Higher Education «Saratov State Medical University n. a. V. I. Razumovsky» of the Ministry of Health of the Russian Federation
1 shared publication- Nataliia M. Nikitina
Saratov State Medical University named after V.I. Razumovsky
1 shared publication Г. А. Хальметова
Federal State Budgetary Educational Institution of Higher Education «Saratov State Medical University named after V.I. Razumovsky» of the Ministry of Health of the Russian Federation
1 shared publication
Latest Publications
- Open Access
- 1 September 2022
- Published by Rostov State Medical University in South Russian Journal of Therapeutic Practice
- Vol. 3 (3) , 97-107
Markable coagulopathy in the patient with severe COVID-19
The variative coagulation abnormalities with thrombotic and microvascular complications are distinguishing feature of the severe new coronavirus infection (COVID-19) pathogenesis. Abnormal coagulopathy is directly related to the risk of death in COVID-19 patients. In many patients with COVID-19, hemostasis disorders have been observed, which increase the risk of developing DIC (disseminated intravascular coagulation), thrombotic microangiopathy or antiphospholipid syndrome as a result of the pathogenetic factors combination: inflammatory response, endothelial dysfunction, increased platelet consumption, microvascular thrombosis. The mechanism of coagulopathy associated with COVID is still being found, COVID-associated coagulopathy exemplifies the potentiating multi-factor interactions between the immune system and the coagulation. We’re reporting a fatal case of 51-year-old male with COVID-19, complicated by severe acute respiratory syndrome (SARS) and severe thrombocytopenia, markedly enhanced fibrinolytic activity with skin-hemorrhagic syndrome, thrombotic complication (myocardial infarction), probably related to the DIC. This case demonstrates the need more basic and clinical research is warranted to further our understanding of the role of coagulation disorders mechanism in COVID-19 to prevent severe outcomes and mortality.
- 1 September 2022
- Published by Rostov State Medical University in South Russian Journal of Therapeutic Practice
- Vol. 3 (3) , 97-107
Open AccessMarkable coagulopathy in the patient with severe COVID-19
The variative coagulation abnormalities with thrombotic and microvascular complications are distinguishing feature of the severe new coronavirus infection (COVID-19) pathogenesis. Abnormal coagulopathy is directly related to the risk of death in COVID-19 patients. In many patients with COVID-19, hemostasis disorders have been observed, which increase the risk of developing DIC (disseminated intravascular coagulation), thrombotic microangiopathy or antiphospholipid syndrome as a result of the pathogenetic factors combination: inflammatory response, endothelial dysfunction, increased platelet consumption, microvascular thrombosis. The mechanism of coagulopathy associated with COVID is still being found, COVID-associated coagulopathy exemplifies the potentiating multi-factor interactions between the immune system and the coagulation. We’re reporting a fatal case of 51-year-old male with COVID-19, complicated by severe acute respiratory syndrome (SARS) and severe thrombocytopenia, markedly enhanced fibrinolytic activity with skin-hemorrhagic syndrome, thrombotic complication (myocardial infarction), probably related to the DIC. This case demonstrates the need more basic and clinical research is warranted to further our understanding of the role of coagulation disorders mechanism in COVID-19 to prevent severe outcomes and mortality.
- Open Access
- 31 May 2020
- Published by Synapse, LLC in The Russian Archives of Internal Medicine
- Vol. 10 (3) , 230-236
Takotsubo Syndrome in a Young Man
Развитие синдрома такоцубо у мужчины молодого возраста
- 31 May 2020
- Published by Synapse, LLC in The Russian Archives of Internal Medicine
- Vol. 10 (3) , 230-236
Open AccessTakotsubo Syndrome in a Young Man
Развитие синдрома такоцубо у мужчины молодого возраста